Glycated Albumin, a Novel Biomarker for Short-Term Functional Outcomes in Acute Ischemic Stroke

Glycated Albumin, a Novel Biomarker for Short-Term Functional Outcomes in Acute Ischemic Stroke

Background: There is growing interest in the use of new biomarkers such as glycated albumin (GA), but data are limited in acute ischemic stroke. We explored the impact of GA on short-term functional outcomes as measured using the modified Rankin Scale (mRS) at 3 months compared to glycated hemoglobi...

Full description

Bibliographic Details
Main Authors: Yerim Kim, Sang-Hwa Lee, Min Kyoung Kang, Tae Jung Kim, Han-Yeong Jeong, Eung-Joon Lee, Jeonghoon Bae, Kipyoung Jeon, Ki-Woong Nam, Byung-Woo Yoon
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Brain Sciences
Subjects:
glycated albumin
glycated hemoglobin
brain ischemia
stroke
prognosis
biomarkers
Online Access:https://www.mdpi.com/2076-3425/11/3/337

Internet

https://www.mdpi.com/2076-3425/11/3/337

Similar Items